Randomized Trial of Folic Acid Supplementation and Serum Homocysteine Levels
Archives of Internal MedicinePublished 12 March 2001
David S Wald, Lucy Bishop, Nicholas Wald, Matthew Law, Enid Hennessy, Donald G. Weir
Citations200
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
A dosage of folic acid of 0.8 mg/d appears necessary to achieve the maximum reduction in serum homocysteine level across the range of homocy steine levels in the population, indicating that monitoring of the reduction in an individual is impractical.
Abstract
A dosage of folic acid of 0.8 mg/d appears necessary to achieve the maximum reduction in serum homocysteine level across the range of homocysteine levels in the population. Current US food fortification levels will achieve only a small proportion of the achievable homocysteine reduction.
Keywords
MedicineEnvironmental Science
New England Journal of MedicineThe Effect of Folic Acid Fortification on Plasma Folate and Total Homocysteine Concentrations
1,134 Citations1999Paul F. Jacques, Jacob Selhub +3 more
The fortification of enriched grain products with folic acid was associated with a substantial improvement in folate status in a population of middle-aged and older adults.
BMJLowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials
1,082 Citations1998L.E. Brattstrom
Higher blood homocysteine concentrations seem to be associated with higher risks of occlusive vascular disease and with lower blood concentrations of folate and vitamins B-12 and B-6 Large scale randomised trials of such regimens in people at high risk are now needed to determine whether lowering bloodhomocysteined concentrations reduces the risk of vascular disease.
Journal of Chromatography B Biomedical Sciences and ApplicationsDetermination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection
1,050 Citations1987Atsushi Araki, Yoshiyasu Sako
A simple, sensitive and precise method for the determination of both free and total homocysteine in human plasma is presented.
Journal of Chromatography B Biomedical Sciences and ApplicationsRapid high-performance liquid chromatographic assay for total homocysteine levels in human serum
685 Citations1991Job Ubbink, W.J.H. Vermaak +1 more
The HPLC method is simple, sensitive, reproducible and very suitable for routine determination of serum homocysteine levels in a clinical pathology laboratory.
BMJSerum cholesterol concentration and coronary heart disease in population with low cholesterol concentrations.
543 Citations1991Zhengming Chen, Richard Peto +4 more
Blood cholesterol concentration was directly related to mortality from coronary heart disease even in those with what was, by Western standards, a "low" cholesterol concentration.
New England Journal of MedicineReduction of Plasma Homocyst(e)ine Levels by Breakfast Cereal Fortified with Folic Acid in Patients with Coronary Heart Disease
438 Citations1998Manuel R. Malinow, P. Barton Duell +7 more
Cereal fortified with folic acid has the potential to increase plasma folic Acid levels and reduce plasma homocyst(e)ine levels, and further clinical trials are required to determine whether folicacid fortification may prevent vascular disease.
Archives of Internal MedicineHomocysteine and Ischemic Heart Disease
372 Citations1998Nicholas Wald, Hilary Watt +4 more
The epidemiological, genetic, and animal evidence together indicate that the association between serum homocysteine level and ischemic heart disease (IHD) is likely to be causal.
Journal of NutritionVitamin Requirements for the Treatment of Hyperhomocysteinemia in Humans
369 Citations1994Job Ubbink, WJ Vermaak +4 more
F folate deficiency may be an important cause of hyperhomocysteinemia in the general population, and a modest vitamin supplement containing folic acid, Vitamin B-12 and vitamin B-6 is effective in reducing elevated plasma homocysteine concentrations.
BMJSystematic underestimation of association between serum cholesterol concentration and ischaemic heart disease in observational studies: data from the BUPA study
306 Citations1994M R Law, Nicholas Wald +3 more
The association between serum cholesterol concentration and ischaemic heart disease is materially stronger than directly inferred from prospective studies and has important implications for the health benefit of achieving low cholesterol concentrations.
Journal of Clinical PathologyMicrobiological assay on microtitre plates of folate in serum and red cells.
306 Citations1992S. O’Broin, B. Kelleher
A simple microbiological assay for serum and red cell folates on 96-well microtitre plates suitable for use in routine clinical diagnosis and more compact and less time consuming than the traditional assay is developed.
Journal of Clinical InvestigationDeterminants and vitamin responsiveness of intermediate hyperhomocysteinemia (> or = 40 micromol/liter). The Hordaland Homocysteine Study.
261 Citations1996A. B. Guttormsen, Per Magne Ueland +5 more
It is concluded that most subjects with hyperhomocysteinemia in the general population have the C677T mutation combined with low folate status, and daily supplement of low dose folic acid will reduce and often normalize their tHcy level.
Journal of Internal MedicinePlasma homocysteine in acute myocardial infarction: homocysteine‐lowering effect of folic acid
208 Citations1995F Landgren, Bo Israelsson +4 more
It is found that moderate hyperhomocysteinaemia is an independent risk factor for cardiovascular disease which may be causal and treatment with oral folic acid was effective in lowering homocysteine levels in patients with myocardial infarction.
QJMPlasma homocysteine, a risk factor for cardiovascular disease, is lowered by physiological doses of folic acid
207 Citations1997Mary Ward
A dose as low as 200 micrograms/day of folic acid is effective in lowering plasma homocysteine concentrations in apparently normal subjects, and any public health programme for lowering homocrysteine levels, with the goal of diminishing CVD risk, should not be based on unnecessarily high doses offolic acid.
Arteriosclerosis Thrombosis and Vascular BiologyVitamin Supplementation Reduces Blood Homocysteine Levels
164 Citations1998Martin den Heijer, Ingeborg A. Brouwer +9 more
It is shown that combined vitamin supplementation reduces homocysteine levels effectively in patients with venous thrombosis and in healthy volunteers, either with or without hyperhomocysteinemia.
American Journal of Clinical NutritionDietary strategies for lowering homocysteine concentrations
148 Citations2000Lynn Riddell, Alexandra Chisholm +2 more
Daily consumption of folic acid-fortified breakfast cereals and the use offolic acid supplements appear to be the most effective means of reducing tHcy concentrations.
Clinical ChemistryVariability and determinants of total homocysteine concentrations in plasma in an elderly population
139 Citations1998Robert Clarke, P.R. Woodhouse +6 more
The variability of plasma total homocysteine (tHcy) was examined in 96 individuals over a 1-yr period and epidemiological studies based on single tHcy measurements may underestimate the magnitude of any risk associations with disease by 10-15%.
Clinical ChemistryShort-term and long-term variability of plasma homocysteine measurement
118 Citations1997Uttam Garg, Zhi-Jie Zheng +5 more
The data suggest that an individual's plasma homocysteine concentration is relatively constant over at least 1 month, and a single measurement characterizes the average concentration reasonably well.
The American Journal of CardiologyReduction of homocysteine levels in coronary artery disease by low-dose folic acid combined with vitamins B6 and B12
93 Citations1999Arlene Lobo, Arabi Naso +10 more
It is suggested that daily administration of 400 microg/day folic acid combined with vitamin B12 and vitamin B6 may be equivalent to higher doses in reducing homocysteine levels in patients with CAD.
European Journal of Clinical NutritionThe responsiveness of plasma homocysteine to small increases in dietary folic acid: a primary care study
81 Citations1998CJ Schorah, H. Devitt +2 more
If homocysteine is found to be a causative risk factor in occlusive vascular disease, food fortification with physiological levels of folic acid should have a significant impact on the prevalence of the disease in the general population.